OmniAb Investor Presentation Deck

The OmniAb Platform Our discovery teams are flexibly positioned to work closely with partners to identify the right antibody ● ● ● ● Data from multi-parameter screening and performance assays used in combination with bioinformatics NGS hit expansion to identify variant antibodies with improved characteristics High-throughput epitope binning and kinetics analysis, and target-specific functional assays Proprietary assays for ion channel and transporter targets Create Screen 0 Deliver 80 22 OmniAb

View entire presentation